Benign Prostatic Hyperplasia Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Benign Prostatic Hyperplasia stocks.

Benign Prostatic Hyperplasia Stocks Recent News

Date Stock Title
Nov 23 LLY Eli Lilly: Steep Pullback, Still Compelling Here
Nov 23 LLY Billionaire Israel Englander Increased His Stake In Eli Lilly During the Third Quarter: Should You?
Nov 23 LLY Jim Cramer on Eli Lilly and Company (LLY): ‘It’s Valuable’
Nov 23 LLY 2 Incredible Growth Stocks to Buy With $1,000 Right Now
Nov 22 LLY Sanofi Plans to Change Hospital Drug-Discount Program
Nov 22 BSX Why Is Boston Scientific (BSX) Up 7.5% Since Last Earnings Report?
Nov 22 BSX Should You Hold IDEXX Stock in Your Portfolio for Now?
Nov 22 LLY VKTX Stock Loses Over $1B in a Month: How to Play the Stock?
Nov 22 LLY Investing in Pharma Stocks? Check These 3 Things First
Nov 22 LLY Weight-Loss Drugs Don't Seem To Impress RFK Jr. Should Eli Lilly, Novo Nordisk Investors Worry?
Nov 22 SBFM Sunshine Biopharma Launches a New Generic Prescription Drug
Nov 22 LLY Goldman Sachs: Eli Lilly and Company (LLY) Is A Top Growth Investor Stock
Nov 21 LLY The FDA Can’t Decide Whether Zepbound Is in Shortage. It’s Good News for Hims & Hers Stock.
Nov 21 LLY Eli Lilly Stock: Unexpected Developments (Rating Downgrade)
Nov 21 LLY Hims & Hers closes up 10% as Lilly tirzepatide compounding dispute resolution delayed
Nov 21 LLY Eli Lilly Stock Tumbles As Kennedy Targets Weight Loss Drugs
Nov 21 LLY Is Now a Good Time to Buy the Dip in Eli Lilly Stock?
Nov 21 LLY Eli Lilly, Verge announce milestones in ALS collaboration
Nov 21 LLY Versant startup sets out to make a new type of obesity drug
Nov 21 LLY Eli Lilly and 2 More Drug Stocks to Buy After RFK-Inspired Drop
Benign Prostatic Hyperplasia

Benign prostatic hyperplasia (BPH), also called prostate enlargement, is a noncancerous increase in size of the prostate. Symptoms may include frequent urination, trouble starting to urinate, weak stream, inability to urinate, or loss of bladder control. Complications can include urinary tract infections, bladder stones, and chronic kidney problems.The cause is unclear. Risk factors include a family history, obesity, type 2 diabetes, not enough exercise, and erectile dysfunction. Medications like pseudoephedrine, anticholinergics, and calcium channel blockers may worsen symptoms. The underlying mechanism involves the prostate pressing on the urethra thereby making it difficult to pass urine out of the bladder. Diagnosis is typically based on symptoms and examination after ruling out other possible causes.Treatment options including lifestyle changes, medications, a number of procedures, and surgery. In those with mild symptoms weight loss, exercise, and decreasing caffeine intake is recommended. In those with more significant symptoms medications may include alpha blockers such as terazosin or 5α-reductase inhibitors such as finasteride. Surgical removal of part of the prostate may be carried out in those who do not improve with other measures. Alternative medicine, such as saw palmetto, does not appear to help.About 105 million people are affected globally. BPH typically begins after the age of 40. Half of males age 50 and over are affected. After the age of 80 about 90% of males are affected. Although prostate specific antigen levels may be elevated in males with BPH, the condition does not increase the risk of prostate cancer.

Browse All Tags